Monument Therapeutics
Signal active
Organization
Contact Information
Overview
Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2019
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Monument Therapeutics headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $197.2M in funding across 36 round(s). With a team of 1-10 employees, Monument Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Monument Therapeutics, raised $621.8K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$5.5M
Details
1
Monument Therapeutics has raised a total of $5.5M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 3.6M |
Investors
Monument Therapeutics is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Monument Therapeutics | - | FUNDING ROUND - Monument Therapeutics | 1.2M |
| Cambridge Angels group | - | FUNDING ROUND - Cambridge Angels group | 1.2M |
| Monument Therapeutics | - | FUNDING ROUND - Monument Therapeutics | 621.8K |
| Innovate UK | - | FUNDING ROUND - Innovate UK | 621.8K |
Recent Activity
There is no recent news or activity for this profile.